Abilify (aripiprazole) is the first antipsychotic approved for major depressive disorder

Abilify (aripiprazole) is the first antipsychotic approved for major depressive disorder...not just bipolar disorder.

It'll be added to antidepressants to augment their effects.

More than half of patients still have symptoms after starting an antidepressant. If symptoms persist after 4 to 8 weeks, encourage switching to another antidepressant...combining antidepressants...or adding a different type of drug to boost efficacy.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote